Proteomics and opportunities for clinical translation in urological disease.
about
One-step sample concentration, purification, and albumin depletion method for urinary proteomics.Patients with ovarian carcinoma excrete different altered levels of urine CD59, kininogen-1 and fragments of inter-alpha-trypsin inhibitor heavy chain H4 and albuminAn in-depth comparison of the male pediatric and adult urinary proteomesTo label or not to label: applications of quantitative proteomics in neuroscience research.Proteomics of human prostate cancer biospecimens: the global, systems-wide perspective for protein markers with potential clinical utility.Adsorption of urinary proteins on the conventionally used urine collection tubes: possible effects on urinary proteome analysis and prevention of the adsorption by polymer coating.
P2860
Proteomics and opportunities for clinical translation in urological disease.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Proteomics and opportunities for clinical translation in urological disease.
@ast
Proteomics and opportunities for clinical translation in urological disease.
@en
type
label
Proteomics and opportunities for clinical translation in urological disease.
@ast
Proteomics and opportunities for clinical translation in urological disease.
@en
prefLabel
Proteomics and opportunities for clinical translation in urological disease.
@ast
Proteomics and opportunities for clinical translation in urological disease.
@en
P2093
P2860
P1476
Proteomics and opportunities for clinical translation in urological disease.
@en
P2093
Ali R Vaezzadeh
Hanno Steen
Michael R Freeman
Richard S Lee
P2860
P304
P356
10.1016/J.JURO.2009.05.001
P407
P577
2009-07-17T00:00:00Z